Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2675 of 3173 entries
View as:

A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02201511 Org: User:
Start: 09/30/14 End: 10/31/14 Due: 10/31/15

Dalacin-T Gel Post Approval Study

Phase: N/A Priority: Normal
NCT ID: NCT00219570 Org: User:
Start: 01/31/05 End: 06/30/05 Due: 06/30/06

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04889157 Org: User:
Start: 07/07/21 End: 02/17/22 Due: 02/17/23

A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06137703 Org: User:
Start: 08/24/22 End: 12/07/22 Due: 12/07/23

Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00435487 Org: User:
Start: 06/30/07 End: 12/31/08 Due: 12/31/09

Single Dose Study of PF-05230907 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02537002 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

Phase: N/A Priority: Normal
NCT ID: NCT01301456 Org: User:
Start: 03/31/11 End: 04/30/12 Due: 04/30/13

Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00143091 Org: User:
Start: 04/30/05 End: 04/30/06 Due: 04/30/07

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Phase: N/A Priority: Normal
NCT ID: NCT03762928 Org: User:
Start: 12/07/18 End: 02/21/19 Due: 02/21/20

Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429

Phase: N/A Priority: Normal
NCT ID: NCT01117233 Org: User:
Start: 05/31/10 End: 11/30/11 Due: 11/30/12

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161876 Org: User:
Start: 05/31/02 End: 08/31/02 Due: 08/31/03

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00174291 Org: User:
Start: 03/31/02 End: 10/31/11 Due: 10/31/12

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034827 Org: User:
Start: 01/31/02 End: 05/31/03 Due: 05/31/04

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

Phase: N/A Priority: Normal
NCT ID: NCT00391027 Org: User:
Start: 12/31/06 End: 08/31/08 Due: 08/31/09

A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

Phase: N/A Priority: Normal
NCT ID: NCT06291831 Org: User:
Start: 03/13/24 End: 05/13/24 Due: 05/13/25

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01173757 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02609828 Org: User:
Start: 10/28/15 End: 06/25/21 Due: 06/25/22

13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

Phase: N/A Priority: Normal
NCT ID: NCT02034877 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

Phase: N/A Priority: Normal
NCT ID: NCT00195403 Org: User:
Start: 05/31/04 End: 02/29/08 Due: 02/28/09

Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961

Phase: N/A Priority: Normal
NCT ID: NCT04495140 Org: User:
Start: 07/22/20 End: 10/15/20 Due: 10/15/21

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00239928 Org: User:
Start: 09/30/05 End: 11/30/08 Due: 11/30/09

Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00555672 Org: User:
Start: 08/31/08 End: 08/31/10 Due: 08/31/11

Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00907504 Org: User:
Start: 07/31/10 End: 05/31/14 Due: 05/31/15

Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02679755 Org: User:
Start: 03/09/16 End: 07/25/19 Due: 07/25/20

Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01061359 Org: User:
Start: 01/31/99 End: 10/31/09 Due: 10/31/10